On Monday, IO Biotech Inc (NASDAQ: IOBT) was 15.65% up from the session before settling in for the closing price of $1.47. A 52-week range for IOBT has been $0.66 – $1.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -27.25% over the past five years. When this article was written, the company’s average yearly earnings per share was at 5.24%. With a float of $48.43 million, this company’s outstanding shares have now reached $65.88 million.
Let’s look at the performance matrix of the company that is accounted for 80 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
IO Biotech Inc (IOBT) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward IO Biotech Inc stocks. The insider ownership of IO Biotech Inc is 26.49%, while institutional ownership is 21.55%. The most recent insider transaction that took place on May 30 ’25, was worth 20,884. In this transaction Director of this company bought 15,000 shares at a rate of $1.39, taking the stock ownership to the 15,000 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Medical Officer bought 31,350 for $0.85, making the entire transaction worth $26,553. This insider now owns 31,350 shares in total.
IO Biotech Inc (IOBT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 5.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.11% during the next five years compared to -27.25% drop over the previous five years of trading.
IO Biotech Inc (NASDAQ: IOBT) Trading Performance Indicators
You can see what IO Biotech Inc (IOBT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.49, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.09 in one year’s time.
Technical Analysis of IO Biotech Inc (IOBT)
IO Biotech Inc (NASDAQ: IOBT) saw its 5-day average volume 0.44 million, a positive change from its year-to-date volume of 0.17 million. As of the previous 9 days, the stock’s Stochastic %D was 71.21%.
During the past 100 days, IO Biotech Inc’s (IOBT) raw stochastic average was set at 95.65%, which indicates a significant increase from 90.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1160 in the past 14 days, which was higher than the 0.1053 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2967, while its 200-day Moving Average is $1.0491. Nevertheless, the first resistance level for the watch stands at $1.8217 in the near term. At $1.9433, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.1467. If the price goes on to break the first support level at $1.4967, it is likely to go to the next support level at $1.2933. Assuming the price breaks the second support level, the third support level stands at $1.1717.
IO Biotech Inc (NASDAQ: IOBT) Key Stats
There are 65,881K outstanding shares of the company, which has a market capitalization of 111.99 million. As of now, sales total 0 K while income totals -95,490 K. Its latest quarter income was 0 K while its last quarter net income were -22,420 K.
